Par Pacific (PARR) had the highest return between May 30, 2012 and September 30, 2012 by a small-cap US stock, returning 1,650%.
| ASSET | DATE | % RETURN |
|---|---|---|
Par Pacific (PARR) | 5/30/2012 - 9/30/2012 | 1,650% |
Astrana Health (ASTH) | 5/30/2012 - 9/30/2012 | 278.79% |
Sarepta Therapeutics (SRPT) | 5/30/2012 - 9/30/2012 | 264.55% |
Harrow Health (HROW) | 5/30/2012 - 9/30/2012 | 192.31% |
Xpel (XPEL) | 5/30/2012 - 9/30/2012 | 166.67% |
MiMedx (MDXG) | 5/30/2012 - 9/30/2012 | 118.52% |
Transcontinental Realty Investors (TCI) | 5/30/2012 - 9/30/2012 | 95.73% |
Dolly Varden Silver (DVS) | 5/30/2012 - 9/30/2012 | 92.45% |
McEwen Mining (MUX) | 5/30/2012 - 9/30/2012 | 83.6% |
Lendingtree (TREE) | 5/30/2012 - 9/30/2012 | 83.49% |
Hovnanian Enterprises (HOV) | 5/30/2012 - 9/30/2012 | 82.11% |
Spectrum Brands (SPB) | 5/30/2012 - 9/30/2012 | 79.75% |
NeoGenomics (NEO) | 5/30/2012 - 9/30/2012 | 77.06% |
Perion Network (PERI) | 5/30/2012 - 9/30/2012 | 75.06% |
Onity (ONIT) | 5/30/2012 - 9/30/2012 | 72.17% |
Novavax (NVAX) | 5/30/2012 - 9/30/2012 | 71.43% |
Shenandoah Telecommunications (SHEN) | 5/30/2012 - 9/30/2012 | 70.05% |
Northern Dynasty Minerals (NAK) | 5/30/2012 - 9/30/2012 | 69.63% |
Metalla Royalty & Streaming (MTA) | 5/30/2012 - 9/30/2012 | 69.28% |
Arbutus Biopharma (ABUS) | 5/30/2012 - 9/30/2012 | 68.06% |
AMN Healthcare Services (AMN) | 5/30/2012 - 9/30/2012 | 64.92% |
Skeena Resources (SKE) | 5/30/2012 - 9/30/2012 | 64% |
BioLife Solutions (BLFS) | 5/30/2012 - 9/30/2012 | 62.5% |
Smith & Wesson Brands (SWBI) | 5/30/2012 - 9/30/2012 | 62.06% |
MaxLinear (MXL) | 5/30/2012 - 9/30/2012 | 60.82% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
